ArticleScientific reports2025
Kinetics, central composite design and artificial neural network modelling of ciprofloxacin antibiotic photodegradation using fabricated cobalt-doped zinc oxide nanoparticles.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Revisiting Defect-Engineered M(III)-Doped ZnO Photocatalysts for Emerging Pollutant Photodegradation and Mineralization: A Mini-Review.Chemphyschem : a European journal of chemical physics and physical chemistry · 2026Review
- NiCd/ZnO nanocomposites: novel materials for photocatalytic degradation of Allura Red dye.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cobalt-doped zinc oxide nanoparticles were fabricated and examined in this study as a potential photocatalyst for the antibiotic ciprofloxacin (CIPF) degradation when exposed to visible LED light. The Co-precipitation technique created Cobalt-doped zinc oxide nanoparticles that were 5, 10, and 15% Co-loaded. Different known techniques have been used to characterize the synthesized ZnO and cobalt-doped ZnO nanoparticles. Compared to ZnO and other Cobalt-doped ZnO nanoparticles, the experiments showed that 10% Cobalt-doped ZnO nanoparticles were a very effective catalyst for CIPF photodegradation. According to XRD, these NPs have a hexagonal Wurtzite structure with an average size of between 38.47 and 48.06 nm. Tauc plot displayed that the optical energy band-gap of ZnO NPs (3.21) slowly declines with Co doping (2.75 eV). The enhanced photocatalytic activity of Cobalt-doped ZnO nanoparticles, which avoids electron-hole recombination, is brought on by the implantation of Co. Within 90 min, a 30 mg/L solution of ciprofloxacin was destroyed (> 99%). The kinetics studies demonstrated that the first-order model, with R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.